Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube

Rheumatology CE Activities

RMEI PRESENTATIONS

View Details

Proficiency Results From Your Peers at EULAR 2018 and Beyond – Infographic

Proficiency results from your peers at EULAR 2018 and beyond. Topics discussed at our EULAR 2018 symposium. How Cytokines affect RA | Disease Monitoring | When to switch VS cycle drugs | Shared decision making (SDM).
Presentation Year: 2020
Presented at: European Alliance of Associations for Rheumatology (EULAR)
View Details

Proficiency Results From Your Peers at EULAR 2018 and Beyond

Beginning in 2016, RMEI created multiple accredited online educational programs focused on rheumatoid arthritis (RA) and designed for rheumatologists. The 2019 EULAR symposium was a unique opportunity to present the outcomes findings, from both the 2018 symposium and online courses, to the assembled rheumatologists within the context of addressing factors underlying ongoing educational gaps.
Presentation Year: 2020
Presented at: European Alliance of Associations for Rheumatology (EULAR)
View More Presentations

LATEST RHEUMATOLOGY ARTICLES

RSS Latest Rheumatology Articles
  • To B or Not to B — the Role of B-Cell Depletion in Lupus Nephritis April 17, 2025
    B cells play a key role in the pathogenesis of lupus nephritis, yet in the Lupus Nephritis Assessment with Rituximab (LUNAR) trial, rituximab therapy did not improve clinical outcomes after 1 year of treatment.1 The success of anti-CD19 chimeric antigen receptor T cells in selected patients with refractory...
    Andrea Fava
  • Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis April 17, 2025
    In this trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis.
    Richard A. Furie, Brad H. Rovin, Jay P. Garg, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Adolfina Elizabeth Zuta Santillán, Damaris Alvarez, Cleyber Navarro Sandoval, Alexander M. Lila, James A. Tumlin, Amit Saxena, Fedra Irazoque Palazuelos, Harini Raghu, Bongin Yoo, Imran Hassan, Elsa Martins, Himanshi Sehgal, Petra Kirchner, Jorge Ross Terres, Theodore A. Omachi, Thomas Schindler, William F. Pendergraft III, Ana Malvar, the REGENCY Trial Investigators*
  • Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis April 8, 2025
    In two trials in relapsing multiple sclerosis, tolebrutinib (a brain-penetrant BTK inhibitor) was not superior to teriflunomide at reducing annualized relapse rates.
    Jiwon Oh, Douglas L. Arnold, Bruce A.C. Cree, Carolina Ionete, Ho Jin Kim, Maria Pia Sormani, Sana Syed, Yixin Chen, Christina R. Maxwell, Patrick Benoit, Timothy J. Turner, Erik Wallstroem, Heinz Wiendl, the Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group*

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
  • Allergy & Immunology
  • 2021
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
  • Gastroenterology
  • 2021

Previously Published CE Activities

Copyright © 2025. RMEI Medical Education, LLC. All rights reserved​

Privacy | Terms of Use